Evidence map›Paper›PMID 31185033›Full record

Trial reportPloS one2019

Cost of hospital care for the older adults according to their level of frailty. A cohort study in the Lazio region, Italy.

Giuseppe Liotta, Francesco Gilardi, Stefano Orlando, Gennaro Rocco, Maria Grazia Proietti, Federica Asta, Manuela De Sario, Paola Michelozzi, Sandro Mancinelli, Leonardo Palombi and 2 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Frailty in an Adult Acute Hospital Population: Predictors, Prevalence, and Outcomes.International journal of environmental research and public health · 2024
    Article
  10. Observational
  11. Article
  12. Article
  13. Zoledronate Extends Health Span and Survival via the Mevalonate Pathway in a FOXO-dependent Manner.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Giuseppe LiottaUniversity of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy.
Francesco GilardiUniversity of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy.ORCID 0000-0002-4038-6003
Stefano OrlandoUniversity of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy.ORCID 0000-0001-9706-4075
Gennaro RoccoIPASVI Centre of Excellence, Rome, Italy.
Maria Grazia ProiettiOPI, Rome, Italy.
Federica AstaRegione Lazio Department of Epidemiology, Rome, Italy.
Manuela De SarioRegione Lazio Department of Epidemiology, Rome, Italy.
Paola MichelozziRegione Lazio Department of Epidemiology, Rome, Italy.
Sandro MancinelliUniversity of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy.
Leonardo PalombiUniversity of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy.
Maria Cristina MarazziL.U.M.S.A. University, Rome, Italy.
Paola ScarcellaUniversity of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy.
University of Rome Tor Vergata · ITAgenzia Regionale Parchi · ITLibera Università Maria SS. Assunta · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe increasing burden of chronic diseases associated with the ageing of the European population constitutes one of the main challenges for the welfare systems in developed western countries, especially through its impact on the use of hospital services and the cost of care. This study aims at evaluating the cost of hospital care for older adults living in the Lazio Region, Italy, according to their level of frailty.

methodsSince 2014 a longitudinal randomized cohort study has been carried out on a sample consisting of 1280 older adults aged over 64 years resident in the Lazio region (Italy), with their being evaluated for multidimensional frailty. Accesses to Hospital Services (acute care and Day Hospital care admissions and Emergency Room accesses) during the first year after enrolment, as well as the related costs have been recorded through a regional database. Costs have been stratified on the basis of the state of frailty.

resultsThe analysis of hospital services and costs highlights the role played by pre-frail individuals who generated 49.3% of the hospital care cumulative costs. Hospital Admission (HA) costs arising from robust and pre-frail subjects are 70% of the total HA costs. Pre-frail individuals also showed the highest average HA cost per person/year (7062.89 Euros). The main determinant of the highest HA costs was given by the number of HAs during the follow-up (multivariate linear regression, ß coefficient = 0.319; p<0.001), which was higher among pre-frail individuals than in any other group of patients.

conclusionsPre-frail individuals generated the highest cost for hospital care in a sample of representative subjects living in an Italian Region with a low rate of community care services, as is the case in the Lazio region. Assessment of the multidimensional frailty of older adults permits a better definition of the important target of the pre-frail population as the main category within which interventions to prevent or mitigate frailty should be carried out.

Indexed as

Frail ElderlyHospital CostsAgedCosts and Cost AnalysisFemaleFrailtyHumansItalyLongitudinal StudiesMaleMiddle AgedPatient Admission

Identifiers

PMID31185033
PMCPMC6559705
OpenAlexW2951433765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.